Is a lactoferrin level of 11.5 considered high?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Lactoferrin of 11.5 Very High?

Yes, a fecal lactoferrin level of 11.5 μg/g (or mg/g) is elevated and strongly suggests active intestinal mucosal inflammation, most likely from inflammatory bowel disease, requiring endoscopic evaluation.

Understanding Your Result

  • The diagnostic threshold for fecal lactoferrin is 7.25 μg/g - values above this indicate intestinal inflammation with 83% sensitivity and 75% specificity for moderate to severe endoscopic inflammation in IBD 1, 2.

  • Your level of 11.5 is approximately 1.6 times the diagnostic cutoff, placing you clearly in the elevated range that warrants further investigation 1.

  • In patients with moderate to severe symptoms and elevated lactoferrin above 7.25 μg/g, only 3.7% are false positives - meaning 96.3% truly have moderate to severe endoscopic inflammation 1.

What This Means Clinically

This is not a borderline result - it represents definite elevation that requires action:

  • Fecal lactoferrin detects neutrophil-derived inflammation at the molecular level, indicating active mucosal disease rather than simple bleeding from non-inflammatory sources like hemorrhoids 3.

  • Studies show mean fecal lactoferrin levels in active IBD range from 440-1125 μg/g, while healthy controls have levels around 1.27-1.45 μg/g 4, 5.

  • Your level of 11.5 falls between normal and the typical active disease range, but is still significantly elevated above the diagnostic threshold 4, 5.

Immediate Next Steps

The American Gastroenterological Association recommends endoscopic assessment rather than empiric treatment when biomarkers are elevated 6:

  • Colonoscopy with ileoscopy and biopsy is the gold standard for establishing diagnosis and assessing disease extent 6.

  • Perform this within 7-14 days, as early endoscopy is associated with shorter symptom duration and shorter steroid treatment duration 6.

Before Endoscopy, Rule Out Infections:

  • Stool culture for bacterial pathogens (Salmonella, Shigella, Campylobacter, E. coli O157:H7) 6.

  • C. difficile toxin testing to exclude infectious colitis 6.

  • Fecal calprotectin measurement provides quantitative assessment and helps establish which biomarker correlates better with your disease pattern 6.

  • Serum CRP - if elevated >5 mg/L, this provides additional evidence for moderate to severe endoscopic inflammation 6.

Important Clinical Context

Do not delay endoscopy based on symptom severity alone:

  • The National Comprehensive Cancer Network specifically recommends early endoscopy for all patients with positive lactoferrin results, even those with only mild symptoms 6.

  • Elevated lactoferrin can detect inflammation before it becomes visually apparent on endoscopy, and capsule endoscopy or standard colonoscopy can miss subtle mucosal inflammation 2.

Common Pitfall to Avoid

Do not attribute this elevation to hemorrhoids or other non-inflammatory bleeding sources:

  • Hemorrhoids cause bleeding without mucosal inflammation and do not trigger neutrophil infiltration or lactoferrin release 3.

  • If you have both hemorrhoids and elevated lactoferrin, the elevated lactoferrin indicates concurrent intestinal mucosal inflammation requiring investigation 3.

After Diagnosis is Established

  • Repeat fecal calprotectin 2-4 months after starting or adjusting therapy to monitor treatment response 6.

  • Both calprotectin and lactoferrin decline significantly with successful therapy, so serial measurements help guide management 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Elevated Lactoferrin with Clear Endoscopy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fecal Lactoferrin and Intestinal Mucosal Inflammation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Elevated Fecal Lactoferrin: Clinical Interpretation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.